IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA- deficient (IgAD) patients

Clinical and Experimental Immunology

Volumn 112, Issue 3, 1998, Pages 528-532

  Marconi, M ^a   Plebani, A ^b   Avanzini, M A ^c   Maccario, R ^a   Pistorio, A ^c   Duse, M ^b   Stringa, M ^d   Monafo, V ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

CD40 ligand; IgA deficiency; Immunoglobulin production; Interleukins

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIGENS, CD40; CHILD; CHILD, PRESCHOOL; DRUG SYNERGISM; FEMALE; FIBROBLASTS; HUMANS; IGA DEFICIENCY; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MIDDLE AGED; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031835339     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00589.x     Document Type: Article

References (31)

1. Ammann AJ, Hong R. Selective IgA deficiency: presentation of 30 cases and a review of the literature. Med 1971; 50:223-36.
2. Hanson LA, Bjorkander J, Oxelius V. Selective IgA. deficiency. In: Chandra RK, ed. Primary and secondary immunodeficiency disorders. Edinburgh: Churchill Livingstone, 1983:62-84.
3. Plebani A, Ugazio AG, Monafo V, Burgio GR. Clinical heterogeneity and reversibility of selective immunoglobulin A deficiency in 80 children. Lancet 1986; i:829-31.
4. Schaffer FM, Monteiro RC, Volanakis JE, Cooper MD. IgA deficiency. Immunodefic Rev 1991; 3:15-44.
5. Burrows PD, Cooper MD. IgA deficiency. Adv Immunol 1997; 65:245-76.
6. Cassidy JT, Oldham G, Platts-Mills TA. Functional assessment of a B cell defect in patients with selective IgA deficiency. Clin Exp Immunol 1979; 35:296-305.
7. Waldmann TA, Broder S, Krakauer R, Durm M, Meade B, Goldman C. Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency. Trans Assoc Am Physicians 1976; 89:215-24.
8. Islam KB, Baskin B, Christensson B, Hammarstrom L, Smith CI. In vivo expression of human immunoglobulin germ-line mRNA in normal and in immunodeficient individuals. Clin Exp Immunol 1994; 95:3-9.
9. Islam KB, Baskin B, Nilsson L, Hammarstrom L, Sideras P, Smith CI. Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol 1994; 152:1442-52.
10. King MA, Wells JV, Nelson DS. IgA synthesis by peripheral blood mononuclear cells from normal and selectively IgA deficient subjects. Clin Exp Immunol 1979; 38:306-15.
11. Conley ME, Cooper MD. Immature IgA B cells in IgA-deficient patients. N Eng J Med 1981; 305:495-7.
12. Murray PD, McKenzie DT, Swain SL, Kagnoff MF. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol 1987; 139:2669-74.
13. Banchereau J, Rousset F. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol 1992; 52:125-262.
14. Clark LB, Foy TM, Noelle RJ. CD40 and its ligand. Adv Immunol 1994; 63:43-78.
15. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12:881-922.
16. Banchereau J, De Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251:70-72.
17. Splawski JB, Fu MS, Lipsky PE. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 1993; 150:1276-85.
18. Rousset F, Garcia E, Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991; 173:705-10.
19. Hodgkin PD, Castle BE, Kehry MR. B cell differentiation induced by helper T cell membranes: evidence for sequential isotype switching and a requirement tor lymphokines during proliferation. Eur J Immunol 1994; 24:239-46.
20. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 1993; 150:3671-80.
21. Rousset F, Garcia E, Defrance T et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89:1890-3.
22. Brière F, Bridon JM, Chevet D, Souillet G, Bienvenu F, Guret C, Martinez-Valdez, H. Banchereau J. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994; 94:97-104.
23. Friman V, Hanson LÅ, Bridon JM, Tarkowski A, Banchereau J, Briere F. IL-10-driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness. Clin Exp Immunol 1996; 104:432-8.
24. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem 1965; 2:235-54.
25. Plebani A, Ugazio AG, Avanzini MA, Massimi P, Zonta L, Monafo V, Burgio GR. Serum IgG subclass concentrations in healthy subjects at different age: age normal percentile charts. Eur J Pediatr 1989; 149:164-7.
26. Burgio GR, Lanzavecchia A, Plebani A, Jayakar S, Ugazio AG. Ontogeny of secretory immunity: levels of secretory IgA and natural antibodies in saliva. Pediatr Res 1980; 14:1111-4.
27. Plebani A, Mira E, Monafo V, Notarangelo LD, Avanzini MA, Ugazio AG. IgM and IgD concentrations in the serum and secretions of children with selective IgA deticiency. Clin Exp Immunol 1983; 53:689-96.
28. Defrance T, Vanbervliet B, Brière F, Durand I, Rousset F Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175:671-82.
29. van Vlasselaer P, Punnonen J, de Vries JE. Transforming growth factor-beta directs IgA switching in human B cells. J Immunol 1992; 148:2062-7.
30. Eisenstein EM, Chua K, Strober W. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10. J Immunol 1994; 152:5957-68.
31. Punnonen J, Kainulainen L, Ruuskanen O, Nikoskelainen J, Arvilommi H. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency. Scand J Immunol 1997; 45:203-12.